Likewise, our findings also evidence that TERT amplification is a better predictor of tumor-related death than TPM, male sex, tumor multifocality or tumor size ≥ 5 cm, vascular invasion, DMs at diagnosis and/or follow-up, and stage at diagnosis I–II vs. III–IV. The gene discussed is TERT; the disease is neoplasm.